This South Korean company operates as a clinical-stage biopharmaceutical firm, primarily focused on the development of innovative therapies targeting cancer and other serious diseases. Their core strategy revolves around the discovery and advancement of novel small molecule drugs, often employing cutting-edge technologies and scientific approaches. A significant portion of their research and development efforts are dedicated to addressing unmet medical needs, particularly in areas where existing treatments are either ineffective or have significant limitations. They delve into complex biological pathways and mechanisms, aiming to identify unique targets that can be modulated through their drug candidates. This process involves rigorous preclinical testing, including in vitro and in vivo studies, to assess the safety and efficacy of their potential treatments. As a clinical-stage company, they are actively engaged in conducting clinical trials across various phases, often collaborating with leading medical institutions and experts to evaluate the performance of their drug candidates in human subjects. Their pipeline includes a range of assets, each targeting distinct pathways or specific cancer types, reflecting a diversified approach to drug development. Beyond internal research, they also explore strategic partnerships and collaborations to accelerate their programs and leverage external expertise. They strive to secure intellectual property rights to their inventions, protecting their innovations and maximizing their potential for commercialization. The ultimate goal is to bring novel and effective therapies to patients, improving outcomes and enhancing the quality of life for individuals battling severe diseases. Their business model is largely driven by the success of their clinical trials and their ability to obtain regulatory approvals for their drug candidates, setting the stage for potential revenue generation through commercialization activities. They also engage with the scientific community, publishing their findings and participating in scientific discussions, which contribute to advancements in the broader field of medical research.